These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 1397021)
21. Postnatal lead exposure and MK-801 sensitivity. Cory-Slechta DA Neurotoxicology; 1997; 18(1):209-20. PubMed ID: 9216003 [TBL] [Abstract][Full Text] [Related]
22. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. Koek W; Colpaert FC J Pharmacol Exp Ther; 1990 Jan; 252(1):349-57. PubMed ID: 2153806 [TBL] [Abstract][Full Text] [Related]
23. Diphenylhydantoin potentiates the EEG and behavioural effects induced by N-methyl-D-aspartate antagonists in rats. Popoli P; Pèzzola A; Sagratella S Psychopharmacology (Berl); 1994 Jan; 113(3-4):471-5. PubMed ID: 7862861 [TBL] [Abstract][Full Text] [Related]
24. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253 [TBL] [Abstract][Full Text] [Related]
25. Prepulse inhibition of the startle reflex in rats: effects of compounds acting at various sites on the NMDA receptor complex. Depoortere R; Perrault G; Sanger DJ Behav Pharmacol; 1999 Feb; 10(1):51-62. PubMed ID: 10780302 [TBL] [Abstract][Full Text] [Related]
26. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats. Wlaź P; Ebert U; Potschka H; Löscher W Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648 [TBL] [Abstract][Full Text] [Related]
27. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats. Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545 [TBL] [Abstract][Full Text] [Related]
29. Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755. Waters N; Lundgren C; Hansson LO; Carlsson ML J Neural Transm (Vienna); 1996; 103(1-2):117-29. PubMed ID: 9026366 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats. Nicholson KL; Balster RL Psychopharmacology (Berl); 2003 Nov; 170(2):215-24. PubMed ID: 12851738 [TBL] [Abstract][Full Text] [Related]
31. Effects of NMDA receptor inhibition by phencyclidine on the neuronal differentiation of PC12 cells. Lee E; Williams Z; Goodman CB; Oriaku ET; Harris C; Thomas M; Soliman KF Neurotoxicology; 2006 Jul; 27(4):558-66. PubMed ID: 16580729 [TBL] [Abstract][Full Text] [Related]
32. L-glutamate excitation of A10 dopamine neurons is preferentially mediated by activation of NMDA receptors: extra- and intracellular electrophysiological studies in brain slices. Wang T; French ED Brain Res; 1993 Nov; 627(2):299-306. PubMed ID: 7905352 [TBL] [Abstract][Full Text] [Related]
33. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra. Huang KX; Bergstrom DA; Ruskin DN; Walters JR Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877 [TBL] [Abstract][Full Text] [Related]
34. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. Snell LD; Johnson KM J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174 [TBL] [Abstract][Full Text] [Related]
35. A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor. Nevins ME; Arnolde SM Brain Res; 1989 Nov; 503(1):1-4. PubMed ID: 2558775 [TBL] [Abstract][Full Text] [Related]
36. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists. Grant KA; Colombo G J Pharmacol Exp Ther; 1993 Mar; 264(3):1241-7. PubMed ID: 8450461 [TBL] [Abstract][Full Text] [Related]
37. Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966. Jentsch JD; Elsworth JD; Redmond DE; Roth RH J Neurosci; 1997 Mar; 17(5):1769-75. PubMed ID: 9030635 [TBL] [Abstract][Full Text] [Related]
38. N-methyl-D-aspartic acid biphasically regulates the biochemical and electrophysiological response of A10 dopamine neurons in the ventral tegmental area: in vivo microdialysis and in vitro electrophysiological studies. Wang T; O'Connor WT; Ungerstedt U; French ED Brain Res; 1994 Dec; 666(2):255-62. PubMed ID: 7882036 [TBL] [Abstract][Full Text] [Related]
39. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist. Bobelis DJ; Balster RL J Pharmacol Exp Ther; 1993 Feb; 264(2):845-53. PubMed ID: 8437128 [TBL] [Abstract][Full Text] [Related]
40. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat. Umino A; Takahashi K; Nishikawa T Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]